Journal Article

Persistence of Measles, Mumps, and Rubella Protective Antibodies 3 Years after Revaccination in HIV-Infected Children Receiving Antiretroviral Therapy

Linda Aurpibul, Thanyawee Puthanakit, Thira Sirisanthana and Virat Sirisanthana

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 50, issue 10, pages 1415-1418
Published in print May 2010 | ISSN: 1058-4838
Published online May 2010 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/652150
Persistence of Measles, Mumps, and Rubella Protective Antibodies 3 Years after Revaccination in HIV-Infected Children Receiving Antiretroviral Therapy

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus–infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%, and 100%, respectively, 1 month after revaccination.

Journal Article.  2006 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.